NanoQuantum

Working to Create New Paradigms in Diagnosis and Treatment

Nanoquantum is a biotechnology company engaged in the development of new photo-chemical compounds and biological drug carriers, and the integration of these materials into nano-dimensional structures than can identify, target, and potentially rapidly and selectively eliminate biological materials.

We are undertaking these efforts with the goal of opening new doors for diagnostic and therapeutic solutions for many cancers, antibiotic resistant pathogens, and other conditions our core technology can address.

We believe there are new solutions to complicated problems to be found in the realm of photonics at nanometer dimensions where the sciences of physics, chemistry, and biology begin to merge.

 

Products in Development

• Photodynamic super-conjugated nanoparticles (PSCN) consisting of selective filamentous bacteriophage, antibodies, quenchers, reporters, and new photodymamic sub-congugates
• Nanoparticle target-selective drug carrier systems for many pathogens and cancers
• Light source and sensor systems for activation, monitoring, and analytical testing using PSCN and fluorescent tagged phage or antibodies